FDA advisers to discuss future of 'artificial womb' for human infants
Independent advisers to the US Food and Drug Administration will meet Tuesday and Wednesday to discuss the regulations, ethics and possibilities of creating an artificial womb to increase the chances that extremely premature babies would survive — and without long-term health problems.